Soficitinib is a potent and selective TYK2 inhibitor that is being developed for the treatment of various T-cell related autoimmune disorders. The Current indications under development are ...

With me today is our Chief Financial Officer, Anthony Pagano; our Chief Commercial Officer, Brad Bailey; and our Chief ...

Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for ...

One thing about South Asian populations is that we do have a very different presentation of diabetes, partly due to our ...

Italian defence group to show AI system that will connect equipment and platforms to protect nations from air threats ...

Allergen starter kits promise to make introducing foods to babies easier, but experts are concerned they may not be effective ...

The GB Rowing Team are travelling to Birmingham to take part in the World’s largest in-person indoor rowing event – (BRIC) on ...

Walking the myriad halls of the MEDICA convention gives a palpable sense of the innovation bursting at the seams of the ...

LC-HT also let the project quantify the number of branch intersections per cell and the distance of each intersection from ...

The Jewar airport is being developed under a PPP by Yamuna International Airport Private Limited, a subsidiary of Zurich Airport International AG.

Data from patients who remained on tegoprubart for a year post transplant showed an overall mean 12-month estimated glomerular filtration rate (eGFR) of approximately 69 mL/min/1.73 m² Tegoprubart ...

January people come in two varieties. The first type purchases colour-coded planners, enrolls in gym trials, and loudly ...